Rhinitis Medicamentosa Treatment & Management: Medical Care, Surgical Care, Consultations (2024)

  1. Black MJ, Remsen KA. Rhinitis medicamentosa. Can Med Assoc J. 1980 Apr 19. 122(8):881-4. [QxMD MEDLINE Link].

  2. [Guideline] Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008 Aug. 122(2 Suppl):S1-84. [QxMD MEDLINE Link]. [Full Text].

  3. Doshi J. Rhinitis medicamentosa: what an otolaryngologist needs to know. Eur Arch Otorhinolaryngol. 2009 May. 266(5):623-5. [QxMD MEDLINE Link].

  4. De Corso E, Mastrapasqua RF, Tricarico L, Settimi S, Di Cesare T, Mele DA, et al. Predisposing factors of rhinitis medicamentosa: what can influence drug discontinuation?. Rhinology. 2020 Jun 1. 58 (3):233-240. [QxMD MEDLINE Link].

  5. Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol. 2006. 16(3):148-55. [QxMD MEDLINE Link].

  6. Graf P. Rhinitis medicamentosa: a review of causes and treatment. Treat Respir Med. 2005. 4(1):21-9. [QxMD MEDLINE Link].

  7. Graf P. Rhinitis medicamentosa: aspects of pathophysiology and treatment. Allergy. 1997. 52(40 Suppl):28-34. [QxMD MEDLINE Link].

  8. Graf P, Hallen H, Juto JE. The pathophysiology and treatment of rhinitis medicamentosa. Clin Otolaryngol. 1995 Jun. 20(3):224-9. [QxMD MEDLINE Link].

  9. Morissette G, Bouthillier J, Marceau F. Trapping of adrenergic decongestant drugs into cellular endomembrane compartments: toxicological and pharmacological consequences. Int Immunopharmacol. 2007 Dec 20. 7(14):1869-79. [QxMD MEDLINE Link].

  10. Baroody FM, Brown D, Gavanescu L, DeTineo M, Naclerio RM. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011 Apr. 127(4):927-34. [QxMD MEDLINE Link].

  11. Marple B, Roland P, Benninger M. Safety review of benzalkonium chloride used as a preservative in intranasalsolutions: an overview of conflicting data and opinions. Otolaryngol Head Neck Surg. 2004 Jan. 130(1):131-41. [QxMD MEDLINE Link].

  12. Bernstein IL. Is the use of benzalkonium chloride as a preservative for nasal formulations a safety concern? A cautionary note based on compromised mucociliary transport. J Allergy Clin Immunol. 2000 Jan. 105(1 Pt 1):39-44. [QxMD MEDLINE Link].

  13. Graf P. Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa. Clin Ther. 1999 Oct. 21(10):1749-55. [QxMD MEDLINE Link].

  14. Graf P. Benzalkonium chloride as a preservative in nasal solutions: re-examining the data. Respir Med. 2001 Sep. 95(9):728-33. [QxMD MEDLINE Link].

  15. Graf P, Hallen H. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Laryngoscope. 1996 May. 106(5 Pt 1):605-9. [QxMD MEDLINE Link].

  16. Graf P, Hallen H, Juto JE. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers. Clin Exp Allergy. 1995 May. 25(5):395-400. [QxMD MEDLINE Link].

  17. Toohill RJ, Lehman RH, Grossman TW, Belson TP. Rhinitis medicamentosa. Laryngoscope. 1981 Oct. 91(10):1614-21. [QxMD MEDLINE Link].

  18. Osguthorpe JD, Shirley R. Neonatal respiratory distress from rhinitis medicamentosa. Laryngoscope. 1987 Jul. 97(7 Pt 1):829-31. [QxMD MEDLINE Link].

  19. Graf PM, Hallen H. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal. Am J Rhinol. 1997 Jan-Feb. 11(1):67-72. [QxMD MEDLINE Link].

  20. Graf P, Hallen H. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment. ORL J Otorhinolaryngol Relat Spec. 1997 Jan-Feb. 59(1):39-44. [QxMD MEDLINE Link].

  21. Mabry RL. Rhinitis medicamentosa: the forgotten factor in nasal obstruction. South Med J. 1982 Jul. 75(7):817-9. [QxMD MEDLINE Link].

  22. Lekas MD. Rhinitis during pregnancy and rhinitis medicamentosa. Otolaryngol Head Neck Surg. 1992 Dec. 107(6 Pt 2):845-8; discussion 849. [QxMD MEDLINE Link].

  23. Segboer C, Gevorgyan A, Avdeeva K, Chusakul S, Kanjanaumporn J, Aeumjaturapat S, et al. Intranasal corticosteroids for non-allergic rhinitis. Cochrane Database Syst Rev. 2019 Nov 2. 2019 (11):[QxMD MEDLINE Link].

  24. Li W, Misra S, Harvey RJ, Kalish L. Long-term treatment outcomes in refractory rhinitis medicamentosa managed with nasal surgery. Int Forum Allergy Rhinol. 2023 Jul 14. [QxMD MEDLINE Link].

  25. Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR, et al. Clinical practice guideline: allergic rhinitis executive summary. Otolaryngol Head Neck Surg. 2015 Feb. 152 (2):197-206. [QxMD MEDLINE Link].

  26. Baroody FM, Brown D, Gavanescu L, DeTineo M, Naclerio RM. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011 Apr. 127 (4):927-34. [QxMD MEDLINE Link].

  27. Meltzer EO, Bernstein DI, Prenner BM, Berger WE, Shekar T, Teper AA. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis. Am J Rhinol Allergy. 2013 Mar-Apr. 27 (2):102-8. [QxMD MEDLINE Link].

  28. Vaidyanathan S, Williamson P, Clearie K, Khan F, Lipworth B. Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion. Am J Respir Crit Care Med. 2010 Jul 1. 182 (1):19-24. [QxMD MEDLINE Link].

  29. Talaat M, Belal A, Aziz T, et al. Rhinitis medicamentosa: electron microscopic study. J Laryngol Otol. 1981 Feb. 95(2):125-31. [QxMD MEDLINE Link].

  30. Lin CY, Cheng PH, Fang SY. Mucosal changes in rhinitis medicamentosa. Ann Otol Rhinol Laryngol. 2004 Feb. 113(2):147-51. [QxMD MEDLINE Link].

  31. Baldwin RL. Rhinitis medicamentosa (an approach to treatment). J Med Assoc State Ala. 1975 Aug. 47(2):33-5. [QxMD MEDLINE Link].

  32. Behrman RE, Kliegman RM, Jenson HB. Allergic Disorders. In: Nelson Textbook of Pediatrics. 16th ed. Philadelphia, Pa:. WB Saunders. 2000:653-663.

  33. Caffier PP, Frieler K, Scherer H, Sedlmaier B, Göktas O. Rhinitis medicamentosa: therapeutic effect of diode laser inferior turbinate reduction on nasal obstruction and decongestant abuse. Am J Rhinol. 2008 Jul-Aug. 22(4):433-9. [QxMD MEDLINE Link].

  34. Elwany SS, Stephanos WM. Rhinitis medicamentosa. An experimental histopathological and histochemical study. ORL J Otorhinolaryngol Relat Spec. 1983. 45(4):187-94. [QxMD MEDLINE Link].

  35. Fleece L, Mizes JS, Jolly PA, Baldwin RL. Rhinitis medicamentosa. Conceptualization, incidence, and treatment. Ala J Med Sci. 1984 Apr. DA - 19840716(2):205-8. [QxMD MEDLINE Link].

  36. Graf P. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity. Rhinology. 1996 Mar. 34(1):9-13. [QxMD MEDLINE Link].

  37. Graf PM, Hallen H. Changes in nasal reactivity in patients with rhinitis medicamentosa after treatment with fluticasone propionate and placebo nasal spray. ORL J Otorhinolaryngol Relat Spec. 1998 Nov-Dec. 60(6):334-8. [QxMD MEDLINE Link].

  38. Kully B. The use and abuse of nasal vasoconstrictor medication. JAMA. 1945. 127:307-310.

  39. Lasley MK. Rhinitis and sinusitis in children. 1999. 19:437-448.

  40. Scadding GK. Rhinitis medicamentosa [editorial]. Clin Exp Allergy. 1995 May. 25(5):391-4. [QxMD MEDLINE Link].

  41. Wang JQ, Bu GX. Studies of rhinitis medicamentosa. Chin Med J (Engl). 1991 Jan. 104(1):60-3. [QxMD MEDLINE Link].

  42. Yoo JK, Seikaly H, Calhoun KH. Extended use of topical nasal decongestants. Laryngoscope. 1997 Jan. 107(1):40-3. [QxMD MEDLINE Link].

Rhinitis Medicamentosa Treatment & Management: Medical Care, Surgical Care, Consultations (2024)

References

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Lakeisha Bayer VM

Last Updated:

Views: 5966

Rating: 4.9 / 5 (49 voted)

Reviews: 88% of readers found this page helpful

Author information

Name: Lakeisha Bayer VM

Birthday: 1997-10-17

Address: Suite 835 34136 Adrian Mountains, Floydton, UT 81036

Phone: +3571527672278

Job: Manufacturing Agent

Hobby: Skimboarding, Photography, Roller skating, Knife making, Paintball, Embroidery, Gunsmithing

Introduction: My name is Lakeisha Bayer VM, I am a brainy, kind, enchanting, healthy, lovely, clean, witty person who loves writing and wants to share my knowledge and understanding with you.